Original Research
Accepted on 19 Jan 2026
Impact of Immune-Related Adverse Events on Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors
in Cancer Immunity and Immunotherapy
- 117 views
Original Research
Accepted on 19 Jan 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 19 Jan 2026
in Mucosal Immunity
Brief Research Report
Accepted on 19 Jan 2026
in B Cell Biology
Original Research
Accepted on 19 Jan 2026
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 19 Jan 2026
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 19 Jan 2026
in Parasite Immunology
Review
Accepted on 19 Jan 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 19 Jan 2026
in Nutritional Immunology
Original Research
Accepted on 19 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 19 Jan 2026
in Microbial Immunology
Mini Review
Accepted on 19 Jan 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 19 Jan 2026
in Mucosal Immunity
Original Research
Accepted on 19 Jan 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 19 Jan 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Review
Accepted on 19 Jan 2026
in Viral Immunology
Review
Accepted on 19 Jan 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 19 Jan 2026
in Inflammation
Systematic Review
Accepted on 19 Jan 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 19 Jan 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 19 Jan 2026
in Inflammation
Original Research
Accepted on 19 Jan 2026
in Inflammation
Original Research
Accepted on 19 Jan 2026
in Inflammation
Editorial
Published on 19 Jan 2026
in Cancer Immunity and Immunotherapy
Review
Published on 19 Jan 2026
in Cancer Immunity and Immunotherapy